Now that Canada finally has a date for the recreational market start, the federal government, provinces and other regulatory authorities are beginning to issue guidelines and rules that are going to define the early days of the recreational industry.
These include regulations on retail trade, medical sales and use. However this is precisely where the confusion is growing.
The Government Will Continue To Run The Medical Cannabis System
In a move to protect patients, Health Canada has announced that it will continue to run the medical part of the market for at least the next five years. In good news for medical users, this announcement was made against calls from the Canadian Medical Association for the medical infrastructure developed on Canada’s path to recreational reform to be phased out. The reason, according to the CMA? Many doctors feel uncomfortable prescribing the drug because of a lack of research and a general lack of understanding about dosing.
Both patients and advocates have expressed support for continuing the medical system. This includes organizations like the Canadian Nurses Association who fear that if a focus is taken off of medical use, producers will ignore this part of the market to focus only on recreational sales.
In the future, after legalization, Health Canada will also continue to support more research and trials.
Provinces Are Setting Their Own Rules For Recreational Sales
Despite early statements, the recreational market is still in the throes of market …
While the US boasts the largest economy and stock market in the world, with giants Apple, Netflix and Google, Canada offers the largest cannabis companies for now.
To be sure, US cannabis companies such as MedMen Enterprises Inc. and Terra Tech Corp. have been expanding quickly. But Canada’s Tilray Inc., Canopy Growth Corp., Aurora Cannabis Inc., Aphria Inc., Cronos Group Inc. and others have bulked up significantly. The leading Canadian company, British Columbia-based Tilray, is currently valued at $14.4 billion.
With adult-use sales scheduled to begin in Canada on October 17, the spigot of capital has opened as investors pour money into the nation’s top pot stocks. The total cannabis market in Canada, including medical and recreational products, may yield up to $5.4 billion (C$7.2 billion) in sales next year, according to estimates from Deloitte.
With an eye on this growth, financiers and executives have been eager to offer investors new options. Tilray’s shares jumped 30% in their stock market debut on the NASDAQ on July 19, giving the company a total market value of $2.7 billion at the time. It’s a rich price tag for a business on track to earn just $80 million this year.
The National Organization for the Reform of Marijuana Laws (NORML) endorses Proposition 2: The Utah Medical Cannabis Act, which regulates the licensed production and distribution of medical cannabis products to qualified patients who possess a physician’s recommendation.
Seventy-seven percent of adults express support for the law change, according to statewide polling data compiled in March.
“Proposition 2 is the result of years of intransigence on the part of Utah politicians who have time and time again refused to move forward with legislation to provide regulated cannabis access to the array of patients who could benefit from it,” NORML Political Director Justin Strekal said.
Under legislation enacted by the legislature in 2018, only those patients who are terminally ill may potentially access cannabis-infused products. To date, however, such products are not yet legally available.
“Passage of Proposition 2 will assure that those patients with qualified debilitating conditions who need medical cannabis have access to lab-tested products via a tightly regulated system of licensed, above-ground state-licensed facilities,” Strekal added.
If enacted by voters this November, Utah would become the 32nd state to permit patients’ access to medical cannabis.
To sell more cannabis products, you must build trust with your customers. Design Shack Magazine explains: “Trust is a key component of user loyalty, and a reason why people come to your company or brand.”
If you don’t get your package design right, people might simply ignore your cannabis products.But building trust is a big challenge for new medical cannabis businesses. That’s where good design can help:“While a lot of trust comes from past performance and a brand’s track-record, it also comes from the design. How a website, poster or package looks can impact how users feel about it and whether they take the leap from casual looker to brand loyalist.”
For a cannabis health supplement business, the product packaging design is one of the most important ways to reassure consumers and build trust.
When a prospective customer first sees your product, they see the packaging before they can touch or see the product. Good product packaging can raise concerns or instill comfort and confidence in a potential buyer.
If you don’t get your package design right, people might simply ignore your cannabis products.
So, let’s take a look at what your business can do to create great product packaging designs that will win over the skeptics and gain customers.
Include the Right Content On Product Packaging
Designing packaging that inspires trust starts with including the right content.
Start by telling people exactly what’s inside your packaging. …
Market cap: $14.5 billion; owns Ontario-based LP, Tweed; with it’s recent $4 billion investment, Constellations Brands, whose stable of alcohol companies includes Corona and Mondavi, now owns 38% of Canopy.
Market cap: $7.3 billion; Alberta-based LP also owns Ontario-based LP, MedRelief Corp. as well as subsidiaries CannaMed and Hempco Food and Fiber; on Sept. 17, it was reported that Coca-Cola had contacted Aurora about launching a CBD soft drink in Canada.
NORML staff today responded to reports that the US Customs and Border Protection Agency will enforce a federal policy denying entry into the United States any individual involved Canada’s burgeoning marijuana market. Under the policy, US officials are to bar entry to Canadians who acknowledge having consumed marijuana at any time in their past, as well as those who are either employed or invested in legal cannabis enterprises.
Canada legalized the regulated production and distribution of medical cannabis in 2,000. In June of this year, Canadian lawmakers gave final approval to separate legislation regulating the adult use marijuana market. The new law takes effect on October 17, 2018.
“This is an irrational and discriminatory policy that unduly penalizes tens of thousands of Canadians who pose no health or safety risk to the United States. Let’s be clear: these are people engaged in activity that is legal in their home country of Canada — and it is activity that is also legally regulated in a majority of US states,” NORML Deputy Director Paul Armentano said. “Further, to inappropriately classify those who are either employed or simply have invested in the Canadian cannabis industry, an industry that has been legal in Canada for well over a decade already, as drug traffickers fails to pass the smell test.”
He added, “At a time when public opinion and the culture around marijuana is rapidly shifting, not just in the US but around the world, …
Welcome to the latest edition of NORML’s Weekly Legislative Roundup!
The U.S. House Judiciary Committee approved legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions which limit investigators ability to clinically study marijuana in a manner similar to other controlled substances.
On the other hand, a congressional conference committee opted not to include a Senate-passed provision in a bill to fund the U.S. Department of Veterans Affairs. The measure is known as the Veterans Equal Access Amendment, which sought to facilitate veterans’ access to medical cannabis in jurisdictions that regulate it.
Also, U.S. Senator Dianne Feinstein (D-CA), one of Congress’s more ardent drug warriors—signed on as a cosponsor of the STATES Act, to remove the threat of federal intervention and prosecution in states that regulate marijuana use and sales.
At the state level, New Mexico’s health secretary approved adding obstructive sleep apnea as a medical cannabis qualifying condition, but rejected adding opioid addiction, muscular dystrophy, Tourette’s syndrome, eczema and psoriasis. Separately, regulators are holding a series of public meeting next month to receive feedback on proposed hemp rules.
Vermont’s marijuana legalization study committee held a meeting. And California Gov. Jerry Brown (D) signed a bill prohibiting the marketing of cannabis products on websites used by minors.
After the murder of Botham Jean by Dallas Police Officer Amber Guyger, in his own home, some, but not all, of the search warrants that were executed were released to public record. One of which, that was released the same day as Botham Jean’s funeral, listed a small amount of marijuana among the items found in Jean’s apartment.
Commenting on the developments, NORML Executive Director Erik Altieri stated:
“The release of a Dallas police affidavit into the public record regarding marijuana found in Botham Jean’s apartment is nothing more than an attempt by law enforcement and the media to posthumously criminalize and cast aspersions on a man who by all accounts is guilty of nothing other than sitting quietly in his own home. Over half of all Americans have consumed marijuana at some point in their lives and to pretend in any way the possession of a plant that is objectively safer than alcohol or tobacco provides legitimacy to his extrajudicial execution is disgusting and egregious. Whether or not the victim possessed marijuana is irrelevant to the case and a sad attempt to slander an otherwise innocent person. Botham Jean and his family need and deserve justice, not a pathetic attempt at a smear campaign.”
You can read more about this developing situation here and here.
Nevada State Senator Richard “Tick” Segerblom descends from a long line of legislators. In November, he’s running for a spot on the Clark County Commission. Segerblom, who’s also an attorney, was instrumental in getting marijuana legalized in the Silver State and continues to monitor developments. He’s also a member of Freedom Leaf’s board of directors.
Was it inevitable that you would go into politics?
I’m a fourth-generation Nevada legislator. My great-grandfather was a state senator from Winnemucca, my grandmother was an assemblywoman from Winnemucca and my mother was an assemblywoman from Boulder City, so I’d say it was inevitable that I would try to serve to keep the streak going. Seriously, I had a keen interest from early on because I saw how government could have a very positive role in a community and be a force for good. I got my first chance working for Jimmy Carter’s administration and never looked back.
You’ve been a member of the Nevada legislature since 2007. What have been your greatest accomplishments?
There are many bills I’m proud to have signed onto, including increased education funding and greater worker protections. I’m especially proud of working with other legislators to create the state’s first workable medical marijuana framework in 2013 and then working to improve that system in 2015 and 2017. We’ve come a very long way since voters first put the right to medical marijuana in the state’s constitution in 2000.
On Sept. 7th, 2018, the Interim Joint Judiciary Committee held a meeting to discuss medical marijuana and the bill being proposed by Rep. Nemes (R-), Rep. St. Onge (R-), Rep. Hart (R-) and Rep Sims (D-). They discussed their bill and invited Louisville resident Cassie Everett and her family to speak at the event. Link to articleLink
Rep. Jason Nemes, R-Louisville, presents information on proposed legislation on medical marijuana for the 2019 Regular Session of the General Assembly during the Interim Joint Committee on Licensing, Occupations, and Administrative Regulations. Link to article
A Rare Moment of Bi-Partisan Agreement is Underway for Sen. McConnell Sponsored “Hemp Farming Act” (Link to article).
September 14th – Licensing, Occupations, & Administrative Regulations – 10 am – The Capitol, Frankfort, KY
September 18th – KY NORML General Meeting – One Love Hemp Dispensary, 1908 Bardstown Rd., Louisville, KY 40205. Meeting from 5:30 PM – 6:30 PM.Ice Cream Social Put on by Cozmic Gardens from 5 PM – 6:30 PM.…
Federal recreational reform is coming to Canada next month, the second country after Uruguay to take the plunge. For the first time in almost a century, in other words, cannabis is now about to be legal again.
The federal government will license and regulate the industry. However each province and territory (analogous to American states) will set the rules on distribution and sales. As a result, there is quite a bit of difference across the country with implications both for licensed producers (LPs) and consumers.
Who Can Buy, Sell and Grow?
With two exceptions, the legal age of consent is 19, home growing of up to 4 plants is allowed across many provinces (with only Quebec, Manitoba and Nunavut banning the practice), and rules vary by province on both public and private consumption.
However what the industry is really looking at right now is where private enterprise will be allowed to flourish at the retail end of the industry. Private retailers will be allowed to operate in 7 provinces and territories where they will compete with government run outlets. In New Brunswick, Nova Scotia, Ontario, Prince Edward Island, Quebec and the Yukon, consumers will be required to shop in only government-run establishments.
Nunavut, with no licensed producers, will allow online sales only, even in a recreational market. This gives Tilray an instant advantage with their established online …
Members of the House Judiciary Committee voted today in favor of legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions which limit investigators ability to clinically study marijuana in a manner similar to other controlled substances.
“The federal hurdles in place that currently discourage clinicians from engaging in clinical cannabis research have long been onerous and irrational,” NORML Deputy Director Paul Armentano said. “It is high time that lawmakers recognize this problem and take action to amend it so that investigators may conduct the same sort of high-quality clinical research with cannabis that they do with other substances.”
Currently, federal regulations mandate that investigators participating in FDA-approved clinical trials involving cannabis must obtain marijuana from a single, federally-licensed source, the University of Mississippi. However, many of those familiar with their product have criticized its quality, opining that it possesses subpar potency, is often poorly manicured, and that it does not accurately reflect the wide variety of cannabis products and strains available to consumers.
As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected that decision. In 2016, the DEA publicly changed its stance and …
The National Organization for the Reform of Marijuana Laws (NORML) is pleased to endorse Proposal 1: The Michigan Regulation and Taxation of Marihuana Act, which will appear on November’s electoral ballot.
The initiative permits those over the age of 21 to possess and grow personal use quantities of cannabis and related concentrates, while also licensing activities related to commercial marijuana production and retail marijuana sales.
“NORML endorses Proposal 1 because it will bring an end to the criminal arrest and prosecution of tens of thousands of adults annually, while generating new economic and tax revenue for the state of Michigan,” said NORML Political Director Justin Strekal. “Voters in recent years have consistently voted ‘yes’ on these types of adult use ballot measures, and we believe that Michigan’s voters will similar embrace this common-sense proposal.”
Over 56 percent of likely voters say they back the passage of Proposal 1, according to polling data released this week by The Detroit News. Among voters between the ages of 18 and 39, over 70 percent support the ballot initiative.
If enacted by voters this November, Michigan will become the tenth US state to regulate adult marijuana use.
Proponents of the effort, The Coalition to Regulate Marijuana Like Alcohol, include members of Michigan NORML, the Marijuana Policy Project, the ACLU of Michigan, the Drug Policy Alliance, the National Patients Rights Association MI Legalize, the Michigan Cannabis Coalition, and lawyers from the State Bar of Michigan …
The 29th Annual Boston Freedom Rally commences on Friday, Sept. 14 on Boston Common and continues until Sunday, Sept. 16. More than 40 bands will perform on the two stages and over 100 speakers will address the crowd from the stages and Education Village. Freedom Leaf’s Steve Bloom will be there, speaking and reporting back from the East Coast’s No. 1 cannabis event. Thousands of supporters are expected to attend the rally. No rain is in the forecast and temps will be in the high 70s and low 80s. Here’s the schedule:
As the summer months come to a close and as political campaigns around the country ramp up outreach efforts, NORML chapters are working to make sure that supporters of marijuana law reform efforts are registered to vote. Through our partnership with Rock the Vote, we’ve made it quick and easy for our members and supporters to make sure their voices are heard this November. This is especially important in states like Missouri, Michigan, North Dakota and Utah — where marijuana law reform initiatives will appear on ballot this November.
“With Missouri’s voter registration deadline quickly approaching, it’s important for supporters of Amendment 2 to make sure they’re registered to vote. Historically, marijuana ballot initiatives perform better when younger people vote. Voter turnout will absolutely be a factor in the outcome of this November’s election,” said Jamie Kacz, Secretary of Missouri NORML.
Also, to help educate our members and supporters about candidates who are supportive of marijuana law reform efforts, NORML is working with “Smoke the Vote” to create state-level and congressional scorecards, similar to our Governor Scorecard, that …
In addition to several marijuana initiatives (in Michigan, Missouri, North Dakota and Utah) on the Nov. 6 ballot, a number of races in the Senate and House could result in pro-pot candidates knocking off drug warriors. Here are 10 races to watch.
Beto O’Rourke is challenging incumbent right-winger Cruz. O’Rourke, who’s backed the legalization cause ever since he was on El Paso’s City Council, has repeatedly called for the end of “the U.S. government’s War on Drugs” and “the federal prohibition of marijuana.” An O’Rourke victory would help swing the Senate back to Democratic control. The congressman has the support of Willie Nelson, who he performed with on stage at the singer’s Fourth of July Picnic in Austin. It’s an expensive race with a total of $37 million ($23.7 million for O’Rourke) in the campaigns’ coffers. An Aug. 27 Emerson College poll called the race a “dead heat,” though most prognosticators say it’s “likely Republican.” In recent weeks, Cruz’s campaign has been pulling out all the stops, releasing O’Rourke’s mug shot from a 1998 DWI and longhaired photos from when he played bass in a punk-rock band.
There really is no question that Light Emitting Diodes (LEDs) work, but just how well do they work?
For the last 50+ years, indoor cannabis cultivators have used High Pressure Sodium (HPS) lights to illuminate their flowering crops. This technology was developed for, and is still used, as street lighting and there really hasn’t been a fundamental change to the output in the last half century.LED technology showed great promise to solve some of the primary drawbacks to the use of HPS technology for indoor cannabis cultivation.
We are often asked why this technology was used to grow cannabis, and the answers are simple: 1) due to strict legislation and even stricter penalties for growing cannabis, growers wished to move their crops indoors, and, 2) there really hasn’t been another technology that would allow us to cheaply place 400, 600, or even 1000W of light on a crop. In addition, HPS technology is rich in certain frequencies of red light, which is so important to flowering crops. Unfortunately, HPS lamps have their drawbacks, such as high heat output and lack of other “colors,” along the lighting spectrum. In fact, up to 95% of light produced by an HPS lamp is emitted in the infrared range, which we perceive as heat.
Enter the Light Emitting Diode. LED technology showed great promise to solve some of the primary drawbacks to the use of HPS technology for indoor cannabis cultivation. The ability …
Lawmakers have removed language from pending federal legislation that sought to facilitate veterans’ access to medical cannabis in jurisdictions that regulate it.
The decision to strip out the Veterans Equal Access Amendment flies in the face of the horrific medical realities that our nation’s heroes who are desperate to mitigate. This move thwarts the will of the majority of Americans who support medical marijuana and 81% of veterans who believe that the federal government should protect its therapeutic access. Further, by not creating protections for veterans, the Congress continues to view 22% of those who have worn the uniform as criminals.
Under existing federal regulations, physicians affiliated with the US Department of Veterans Affairs are prohibited from filling out the necessary paperwork required in legal medical marijuana states. A budgetary amendment included in the Senate’s version the Military Construction, Veterans Affairs and Related Agencies Appropriations bill sought to end this prohibition. However, Congressional leaders this week elected to eliminate the provision during hearings to reconcile the House and Senate versions of the appropriations bill.
Congressman Earl Blumenauer, the author of similar legislative language now pending in the House of Representatives, said “Denying veterans the care they need by the doctors they trust is shameful. The Senate passed this amendment. It has broad bipartisan support in the House. This should have been a no brainer. Yet, Republican leadership has once again stymied progress toward fair and equal treatment for our …